Psoriatic Arthritis

Psoriatic Arthritis | Unmet Need | US/EU | 2019

MARKET OUTLOOK

Although TNF-alpha inhibitors remain the preferred choice for psoriatic arthritis (PsA) treatment following conventional DMARDs, the more recently introduced IL-17 inhibitors,…